Analyst Ratings for CVS Health (CVS )
CVS Rating Summary
CVS Price Target Summary
- Highest: $126.00 (UBS)
- Lowest: $80.00 (Jefferies)
- Average: $105.90
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$105.90 (+11.8%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
Avg. $ Target:
$105.90 (+11.8%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/20/2026 | Nephron | Eric Percher | New Coverage | Hold (N/A) |
84.00 (N/A) |
77.30 (94.72) |
22.54% | Details |
| 3/12/2026 | Bernstein SocGen Group » Updated 5/12/2026 |
Lance Wilkes | Upgrade | Outperform (Market Perform) |
106.00 (94.00) |
75.72 (94.72) |
25.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
